Considerations For Transitioning V.a.c.® Therapy Into Home Care - KCI V.A.C.VIA Manuel D'instructions

CONSIDERATIONS FOR TRANSITIONING V.A.C.® THERAPY INTO HOME
CARE
WARNING: Patients with an increased risk of bleeding complications should be treated and
monitored in a care setting deemed appropriate by the treating physician.
In addition to the contraindications, warnings and precautions for use of V.A.C.® Therapy, consider the
following before prescribing V.A.C.® Therapy for use in the home care setting.
•
The Patient's Situation:
•
Clinical condition (adequate hemostasis and a low risk of active and / or large amounts of
bleeding at the wound site)
•
Home environment (patient or family member / caregiver able to read and understand
safety labeling, able to respond to alarms, able to follow instructions for use)
•
The Patient's Wound:
•
Must be assessed for exposed vessels, anastomotic sites, organs, and nerves. Adequate
protection must be present without the need for a protective, non-adherent layer placed
between the V.A.C.® Dressing and the exposed structure for the sole purpose of protection
of these structures (refer to Protect Vessels and Organs in the Warnings section).
•
Labeling:
•
The prescribing physician and health care clinician should be familiar with the V.A.C.®
Therapy instructional materials that accompany the therapy unit and dressing cartons into
the home. The prescribing physician and / or healthcare clinician should carefully review
these materials with the patient and patient's caregiver.
•
KCI offers in service and training programs for use of V.A.C.® Therapy. Contact your local KCI
representative. In the U.S., call 1-800-275-4524 for scheduling.
If there are any questions regarding the proper placement or usage of V.A.C.® Therapy, please refer to the
V.A.C.® Therapy Clinical Guidelines for more detailed instructions or contact your local KCI representative.
For additional and most current information, please see KCI's website at www.acelity.com or www.
kci-medical.com.
12